Overview
Announcements

Ordinary Adjustment | Solactive US CNS Therapeutics Index | Effective Date 8th May 2025

Solactive US CNS Therapeutics Index:

In the ordinary adjustment, the following composition will be implemented effective open 8th May 2025:

ACADIA PHARMACEUTICALS INC
ALKERMES PLC
AVADEL PHARMACEUTICALS PLC
AXSOME THERAPEUTICS INC
Annexon Inc
BIOGEN INC
DENALI THERAPEUTICS INC
ELI LILLY & CO
HARMONY BIOSCIENCES HOLDINGS INC
JAZZ PHARMACEUTICALS PLC
MIND MEDICINE MINDMED INC
NEUMORA THERAPEUTICS ORD
NEUROCRINE BIOSCIENCES INC
NEW BIOHAVEN
PROTHENA CORP PLC
SUPERNUS PHARMACEUTICALS INC
VERTEX PHARMACEUTICALS INC
XENON PHARMACEUTICALS INC